Foscarnet shortage — IT supply status & alternatives

Foscarnet

—

🇦🇺 AUST R 37310 · Link Medical Products Pty Ltd T/A Link Pharmaceuticals

In supply · Australia

Foscarnet Kabi

In supply · 🇦🇺 Australia · short in🇮🇹 IT🇪🇸 ES

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Foscarnet
Brand names	Foscarnet Kabi
Therapeutic category	Auto-created by Agenzia Italiana del Farmaco — Carenze scraper

Controlled substance	No

Marketing-authorisation holders	FRESENIUS KABI LIMITED, TILLOMED LABORATORIES LIMITED, HIKMA PHARMACEUTICALS USA INC., Link Medical Products Pty Ltd T/A Link Pharmaceuticals +2 more

Registrations on file	6

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

8 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Apitoria Pharma Private LTDTrifarma SPAChem Werth INCLianyungang Runzhong Pharmaceutical CO LTDGland Pharma LTDEmcure Pharmaceuticals LTD+2 more

Manufacturing countries: India, Italy, China · Source: FDA List of Drug Master Files

Verified timeline regulator events

🇮🇹 1 July 2026

critical reported

🇮🇹 3 June 2026

critical reported

🇪🇸 16 Mar 2026

medium reported

🇪🇸 28 Aug 2025

Shortage resolved

🇮🇹 1 Mar 2025

medium reported

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders6 registrations · 6 MA holders

Product	Strength	Form	Market	MA holder	Status
Foscarnet Sodium	24 MG	solution	🇬🇧 GB	FRESENIUS KABI LIMITED	Active
Foscarnet Sodium Tillomed	24 MG	solution	🇬🇧 GB	TILLOMED LABORATORIES LIMITED	Active
Foscarnet Sodium	24mg/mL	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
FOSCAVIR foscarnet sodium	6g	—	🇦🇺 AU	Link Medical Products Pty Ltd T/A Link Pharmaceuticals	Active
Foscarnet Sodium	6000mg/250mL	injection	🇺🇸 US	BAXTER HEALTHCARE CORPORATION	Active
Foscarnet	24mg/mL	injection	🇺🇸 US	FRESENIUS KABI USA, LLC	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.